Retrospective study examines mortality rates in patients using cenobamate vs other antiseizure medications, suggesting safety implications.
To retrospectively examine all-cause mortality in patients after initiating cenobamate vs mortality in patients treated with selected antiseizure medications (ASMs) that have similar patterns of use in medication-resistant epilepsy.
No takes yet. Share an insight, caveat, or question.
Webber et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: